Clinical trial
Lorazepam-Induced Toxicity in the Aged
NCT00044642 · Nathan Kline Institute for Psychiatric Research, Other · Completed
Key facts
| NCT number | NCT00044642 |
|---|---|
| Title | Lorazepam-Induced Toxicity in the Aged |
| Official title | Long-Term Lorazepam Use and Acute Toxicity in the Aged |
| Lead sponsor | Nathan Kline Institute for Psychiatric Research, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Anxiety Disorders, Generalized Anxiety Disorder |
| Intervention type | Drug |
| Interventions | Lorazepam |
| Enrollment | 90 |
| Start date | Dec 1, 2000 |
| Completion | Jul 1, 2007 |
| First posted | Sep 5, 2002 |
| Last update posted | Dec 6, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: